SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WILLIAMS, William V, ERICKSON-VIITANEN, Susan, YELESWARAM, Krishnaswamy, NI, Yong, PARIKH, Bhavnish
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WILLIAMS, William V
ERICKSON-VIITANEN, Susan
YELESWARAM, Krishnaswamy
NI, Yong
PARIKH, Bhavnish
description The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022201582A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022201582A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022201582A13</originalsourceid><addsrcrecordid>eNrjZNANDg0OcfT0c3XRDXL1cXUMdlVw8Q92dHdVcPMP8g1W8HdTCAqN8PfxDPH083TiYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBkZGRgaGphZGjobGxKkCAGAPJlo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB</title><source>esp@cenet</source><creator>WILLIAMS, William V ; ERICKSON-VIITANEN, Susan ; YELESWARAM, Krishnaswamy ; NI, Yong ; PARIKH, Bhavnish</creator><creatorcontrib>WILLIAMS, William V ; ERICKSON-VIITANEN, Susan ; YELESWARAM, Krishnaswamy ; NI, Yong ; PARIKH, Bhavnish</creatorcontrib><description>The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220331&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022201582A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220331&amp;DB=EPODOC&amp;CC=AU&amp;NR=2022201582A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WILLIAMS, William V</creatorcontrib><creatorcontrib>ERICKSON-VIITANEN, Susan</creatorcontrib><creatorcontrib>YELESWARAM, Krishnaswamy</creatorcontrib><creatorcontrib>NI, Yong</creatorcontrib><creatorcontrib>PARIKH, Bhavnish</creatorcontrib><title>SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB</title><description>The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNANDg0OcfT0c3XRDXL1cXUMdlVw8Q92dHdVcPMP8g1W8HdTCAqN8PfxDPH083TiYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBkZGRgaGphZGjobGxKkCAGAPJlo</recordid><startdate>20220331</startdate><enddate>20220331</enddate><creator>WILLIAMS, William V</creator><creator>ERICKSON-VIITANEN, Susan</creator><creator>YELESWARAM, Krishnaswamy</creator><creator>NI, Yong</creator><creator>PARIKH, Bhavnish</creator><scope>EVB</scope></search><sort><creationdate>20220331</creationdate><title>SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB</title><author>WILLIAMS, William V ; ERICKSON-VIITANEN, Susan ; YELESWARAM, Krishnaswamy ; NI, Yong ; PARIKH, Bhavnish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022201582A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>WILLIAMS, William V</creatorcontrib><creatorcontrib>ERICKSON-VIITANEN, Susan</creatorcontrib><creatorcontrib>YELESWARAM, Krishnaswamy</creatorcontrib><creatorcontrib>NI, Yong</creatorcontrib><creatorcontrib>PARIKH, Bhavnish</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WILLIAMS, William V</au><au>ERICKSON-VIITANEN, Susan</au><au>YELESWARAM, Krishnaswamy</au><au>NI, Yong</au><au>PARIKH, Bhavnish</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB</title><date>2022-03-31</date><risdate>2022</risdate><abstract>The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2022201582A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A18%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WILLIAMS,%20William%20V&rft.date=2022-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022201582A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true